Professional Documents
Culture Documents
Chatbots For Diabetes Self Management
Chatbots For Diabetes Self Management
2
Introduction
Diabetes affects 29 million people in the United states each year and costs $245
billion to treat. Successful diabetes management requires that patients create
new habits around medication adherence and glucose monitoring,
dramatically change their diets, and exercise more. Because these changes are
so difficult for people to make, fewer than 50% of patients adhere to treatment
therapies,1 contributing to the nearly 75,000 diabetes deaths per year.2
Chatbots are a new and quickly developing technology that harness the
potential of mHealth while overcoming the shortcomings of existing solutions.
Chatbots rely on artificial intelligence (AI) to create conversational, interactive
experiences through a user’s SMS platform (i.e., text messaging, Facebook
messenger, etc.). Users can interact with a chatbot as they would with a friend
or family member, without requiring a downloaded mobile application. An
evidence-based behavior change chatbot could transform diabetes care by
delivering personalized yet standardized interventions that address the range of
patients’ needs at scale.
3
Depending on specific patient needs, DSME can help patients lose weight,
change their diet, increase physical activity, quit smoking, and build habits
around monitoring blood glucose, taking medication, and checking for signs of
complications.
Programs are very focused on goals that are set collaboratively between the
patient and the care team. The National Standards stipulate that programs are
individualized, so patients are encouraged to come up with their own goals.
National Standards also include monitoring patient progress, so clinical
outcomes are tracked closely.6
There may be some benefits from lifestyle interventions delivered through DSME
programs; however, in practice, many lifestyle interventions place undue
emphasis on health outcomes (like weight loss) and have limited clinical benefit.
Positive impacts are inconsistent across the different types of interventions,7 and
when effects are found, they are small and become smaller over time.8
Furthermore, interventions typically do not impact diabetes risk outcomes or
mortality at all.9
Digital Approaches
Mobile health (mHealth) and internet tools have become increasingly popular
alternatives, or additions, to traditional DSME programs. mHealth in particular
has great potential to expand care delivery as smartphones are ubiquitous and
4
can integrate data from a patient’s numerous connected devices (e.g.
glucometer or Fitbit).
The majority of existing apps focus on only a few needs of a diabetic patient
(e.g., nutrition guidance or glucose monitoring),16 and few focus on addressing
the behavioral or psychological barriers to successful disease management.
Consequently, there is little evidence that these apps improve health
outcomes17 or are a cost-effective approach to delivering DSME.18
Behavioral Shortcomings
Both traditional and mHealth solutions fail to take into account behavioral
perspectives that could greatly improve patient self-management. National
Standards include behavioral goals as an important component for DSME
programs,19 but ‘behavioral goals’ are not clearly defined. Furthermore, the
examples cited to support this component of DSME do not take into account
behavioral science evidence around creating new routines and habits or
overcoming psychological barriers.
mHealth solutions also lack a behavioral science foundation to their design and
instead are overly focused on tracking and trend reporting as mechanisms for
behavior change.20 For example, the MySugr app is centered on tracking and
viewing data trends. Users can track glucose, insulin, carbs, and exercise, and
will estimate HbA1c values if users log their blood glucose values three times a
day for seven days.
5
MySugr Dashboard
Tracking features are typically evaluated favorably and patients believe that
viewing this data improves health.21 However, these ratings and beliefs about
efficacy should not be confused for true drivers of behavior change. While some
forms of self-monitoring, such as recording diet and exercise, can be effective in
certain cases,22 emerging evidence suggests that showing a patient trends in
their clinical values is not effective at changing behavior.23
6
individualized care of traditional DSME programs, while taking advantage of the
scalability of mHealth.
From the user’s perspective, the bot is seen as an expert in a particular domain,
with a personality and human-like characteristics. Over time, as the user
interacts with the bot in a social manner, the user becomes attached to the bot
in much the same way they would with a friend or family member. This social
relationship creates accountability and commitment between the bot and the
user. The bot is responsible for the user’s needs and the user is therefore
compelled to meet the bot’s expectations.
Interacting with a chatbot can feel like interacting a human, except that a
chatbot is much smarter than a human. Behind the scenes, a chatbot app can
integrate data from any connected device, triggering an interaction in
response to flags in the user’s data. The chatbot can provide continuous and
reliable support to the user in an experience that is customized to each patient
but standardized based on predetermined parameters.
Chatbots are unlike other technology solutions because they are personified.
They feel like people so we treat them like people. A chatbot has a name, the
interactions are conversational and responsive, and the experience exists within
the same platforms where users interact with friends and family.
7
same mental models to these human-like interactions that we apply to humans:
we create social contracts, we feel trust and empathy, and we feel social
pressure to not disappoint. Therefore, we can rely on a robot, or chatbot, the
same way we rely on people. We assume they have expectations of us, just as a
friend, family member, or therapist might.
With traditional DSME programs, the more interactions between a patient and a
care provider, the more effective the intervention.25 This is likely because
increased interactions leads to stronger social relationships, which provides
social accountability for the patient’s behaviors. Social interactions are also
salient and meaningful to us, so they may have a greater influence on our
behavior compared to non-social experiences. Chatbots show great promise for
delivering DSME at scale because they can recreate the human element of
these interactions that is likely so powerful for patients.
8
all users a set of behavioral diagnostic questions periodically over time, which
would then inform the type of behavioral interventions the chatbot would
deliver to the user. Users who report having fewer daily habits could be exposed
to interactions with the chatbot that are focused on building new habits,
whereas users with more negative affective responses could be exposed to
interventions focused on mindfulness or other emotion regulation strategies.
A chatbot app has the potential to learn from the user and change the user’s
experience based on previous interactions and the user’s behavior. A chatbot
app could also learn from all of the users and recognize patterns, identify types
of users who respond particularly well to certain types of prompts or
9
interventions, and eventually automatically and precisely funnel users to the
most effective journey or behavioral intervention for them.
Conclusion
Diabetes impacts a large number of Americans each year. Medical and
behavioral treatments are effective but only when patients successfully and
permanently change their behaviors.
1World Health Organization: Adherence to long-term therapies. Evidence for action. Geneva: World Health
Organization; 2003
2Kochanek KD, Murphy SL, Xu J, et al. Deaths: Final data for 2014. National vital statistics reports; vol 65 no 4.
adults with type 2 Diabetes A meta-analysis of the effect on glycemic control. Diabetes care, 25(7), 1159-
1171.
10
4 Hood, M., Wilson, R., Corsica, J., Bradley, L., Chirinos, D., & Vivo, A. (2016). What do we know about mobile
applications for diabetes self-management? A review of reviews. Journal of behavioral medicine, 39(6),
981-994.
5 Chrvala, C. A., et al. (2016). Diabetes self-management education for adults with type 2 diabetes mellitus:
A systematic review of the effect on glycemic control. in Patient Education and Counseling journal.
6 Haas, L., Maryniuk, M., Beck, J., Cox, C. E., Duker, P., Edwards, L., ... & McLaughlin, S. (2012). National
standards for diabetes self-management education and support. The Diabetes Educator, 38(5), 619-629.
7 Chen, L., Pei, J. H., Kuang, J., Chen, H. M., Chen, Z., Li, Z. W., & Yang, H. Z. (2015). Effect of lifestyle
patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Annals of internal
medicine, 159(8), 543-551.
10 Schinckus, L., Van den Broucke, S., Housiaux, M., & Diabetes Literacy Consortium. (2014). Assessment of
(CDC). Diabetes self-management education and training among privately insured persons with newly
diagnosed diabetes–United States, 2011-2012. MMWR Morb Mortal Wkly Rep 2014;63:1045–1049
13 Hood, M., Wilson, R., Corsica, J., Bradley, L., Chirinos, D., & Vivo, A. (2016). What do we know about
mobile applications for diabetes self-management? A review of reviews. Journal of behavioral medicine,
39(6), 981-994.
14 Breland, Jessica Y., Vivian M. Yeh, and Jessica Yu. "Adherence to evidence-based guidelines among
with the UTAUT2 model." Telemedicine and e-Health 21.9 (2015): 735-741.
Lyons, Elizabeth J., et al. "Behavior change techniques implemented in electronic lifestyle activity monitors:
a systematic content analysis." Journal of medical Internet research 16.8 (2014): e192.
Eng, Donna S., and Joyce M. Lee. "The promise and peril of mobile health applications for diabetes and
endocrinology." Pediatric diabetes 14.4 (2013): 231-238.
Brzan, P. P., Rotman, E., Pajnkihar, M., & Klanjsek, P. (2016). Mobile applications for control and self
management of diabetes: A systematic review. Journal of medical systems, 40(9), 210.
16 Hood, M., Wilson, R., Corsica, J., Bradley, L., Chirinos, D., & Vivo, A. (2016). What do we know about
mobile applications for diabetes self-management? A review of reviews. Journal of behavioral medicine,
39(6), 981-994.
17 Holtz, B., & Lauckner, C. (2012). Diabetes management via mobile phones: a systematic review.
standards for diabetes self-management education and support. The Diabetes Educator, 38(5), 619-629.
20 Brzan, P. P., Rotman, E., Pajnkihar, M., & Klanjsek, P. (2016). Mobile applications for control and self
http://www.pwc.com/us/en/industry/entertainment-media/assets/pwc-cis-wearables.pdf
22 Burke, L. E., Wang, J., & Sevick, M. A. (2011). Self-monitoring in weight loss: a systematic review of the
of wearable technology combined with a lifestyle intervention on long-term weight loss: the IDEA
randomized clinical trial. Jama, 316(11), 1161-1171.
11
24 Broadbent, E., Kumar, V., Li, X., Sollers 3rd, J., Stafford, R. Q., MacDonald, B. A., & Wegner, D. M. (2013).
Robots with display screens: a robot with a more humanlike face display is perceived to have more mind
and a better personality. PloS one, 8(8), e72589.
25 Tang, T. S., Funnell, M. M., Brown, M. B., & Kurlander, J. E. (2010). Self-management support in “real-world”
12